Mycobacterium tuberculosis H37Ra and H37Rv differential growth and cytokine/chemokine induction in murine macrophages in vitro

Journal of Interferon and Cytokine Research

Volumn 26, Issue 1, 2006, Pages 27-33

  Freeman, Sherry ^a   Post, Frank A ^b,c   Bekker, Linda Gail ^c   Harbacheuski, Ryhor ^a   Steyn, Lafras M ^c   Ryffel, Bernhard ^c   Connell, Nancy D ^d   Kreiswirth, Barry N ^a   Kaplan, Gilla ^a  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 5; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIOSTASIS; CONTROLLED STUDY; GENE DISRUPTION; GROWTH REGULATION; IN VITRO STUDY; MACROPHAGE ACTIVATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS H37RA; MYCOBACTERIUM TUBERCULOSIS H37RV; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

ANIMALS; CELLS, CULTURED; CHEMOKINES; CYTOKINES; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE SYNTHASE TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; BACTERIA (MICROORGANISMS); MURINAE; MYCOBACTERIUM TUBERCULOSIS;

EID: 32044472859     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2006.26.27     Document Type: Article

References (47)

1. Bean AGD, Roach DR, Briscoe H, France MP, Korner H, Sedgwick JD, Britton WJ. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J. Immunol. 1999;162:3504-3511.
2. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ, Schreiber R, Mak TW, Bloom BR. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995;2:561-572.
3. Roach DR, Bean AGD, Demangel C, France MP, Briscoe H, Britton WJ. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J. Immunol. 2002;168:4620-4627.
4. Lin Y, Zhang M, Barnes PF. Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis. Infect. Immun. 1998;66:1121-1126.
5. Rhoades ER, Cooper AM, Orme IM. Chemokine response in mice infected with Mycobacterium tuberculosis. Infect. Immun. 1995;63: 3871-3877.
6. van Crevel R, Ottenhoff THM, van der Meer JWM. Innate immunity to Mycobacterium tuberculosis. Clin. Microbiol. Rev. 2002;15:294-309.
7. Keane J, Balcewicz-Sablinska MK, Remold HG, Chupp GL, Meek BB, Fenton MJ, Kornfeld H. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect. Immun. 1997;65:298-304.
8. Chan J, Xing Y, Magliozzo RS, Bloom BR. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates by activated murine macrophages. J. Exp. Med. 1992;175:1111-1122.
9. Denis M, Gregg EO, Ghandirian E. Cytokine modulation of Mycobacterium tuberculosis growth in human macrophages. Int. J. Immunopharmacol. 1990;12:721-727.
10. Flesch I, Kaufmann SH. Mycobacterial growth inhibition by interferon-gamma-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis. J. Immunol. 1987;138:4408-4413.
11. Rook GA, Steele J, Ainsworth M, Champion BR. Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages. Immunology 1986;59:333-338.
12. Flynn JL, Chan J, Triebold KL, Dalton DK, Stewart TA, Bloom BR. An essential role for gamma interferon in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 1993;178:2249-2254.
13. Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamijo R, Vilcek J, Zinkernagel RM, Aguet M. Immune response in mice that lack the interferon gamma receptor. Science 1993; 259:1742-1745.
14. Cooper AM, Dalton DK, Stewart TA. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 1993;178: 2243-2247.
15. Denis M. Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cell. Immunol. 1991;132:150-157.
16. Chan J, Tanaka K, Carroll D, Flynn J, Bloom BR. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect. Immun. 1995;63:736-740.
17. MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan CF. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 1997;94: 5243-5248.
18. Manca C, Paul S, Barry CE, Freedman VH, Kaplan G. Mycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro. Infect. Immun. 1999;67:74-79.
19. Manca C, Reed MB, Freeman S, Mathema B, Kreiswirth B, Barry CE, III, Kaplan G. Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis. Infect. Immun. 2004;72:5511-5514.
20. Middlebrook G, Dubos RJ, Pierce C. Virulence and morphological characteristics of mammalian tubercle bacilli. J. Exp. Med. 1947;86:175-184.
21. North RJ, Izzo AA. Mycobacterial virulence. Virulent strains of Mycobacterium tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity. J. Exp. Med. 1993;177:1723-1733.
22. Pierce C, Dubos RJ, Middlebrook G. Infection of mice with mammalian tubercle bacilli grown in tween-albumin liquid medium. J. Exp. Med. 1947;86:159-174.
23. Sever JL, Youmans GP. The enumeration of nonpathogenic viable tubercle bacilli from the organs of mice. Am. Rev. Tuberc. 1957; 75:280-294.
24. Steenken JW, Gardner LU. History of H37 strain of tubercle bacillus. Am. Rev. Tuberc. 1946;54:62-66.
25. Falcone V, Bassey EOE, Toniolo A, Conaldi PG, Collins FM. Differential release of tumor necrosis factor alpha from murine peritoneal macrophages stimulated with virulent and avirulent species of mycobacteria. FEMS Immunol. Med. Microbiol. 1994;8:225-232.
26. Paul S, Laochumroonvorapong P, Kaplan G. Comparable growth of virulent and avirulent Mycobacterium tuberculosis in human macrophages in vitro. J. Infect. Dis. 1996;174:105-112.
27. Hoover DL, Nacy CA. Macrophage activation to kill Leishmania tropica: defective intracellular killing of amastigotes by macrophages elicited with sterile inflammatory agents. J. Immunol. 1984;132:1487-1493.
28. Fortier AH, Hoover DL, Nacy CA. Intracellular replication of Leishmania tropica in mouse peritoneal macrophages: amastigote infection of resident cells and inflammatory exudate macrophages. Infect. Immun. 1982;38:1304-1308.
29. Manca C, Tsenova L, Bergtold A, Freeman S, Tovey M, Musser JM, Barry CE, III, Freedman VH, Kaplan G. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta. Proc. Natl. Acad. Sci. USA 2001;98: 5752-5757.
30. Fortier AH, Falk LA. Isolation of murine macrophages. In: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, and Strober W, eds. Current Protocols in Immunology. New York: John Wiley & Sons, Inc.; 2004:14.1.1-14.1.9.
31. Chensue SW. Molecular machinations: chemokine signals in host-pathogen interactions. Clin. Microbiol. Rev. 2001;14:821-835.
32. Qiu B, Frait KA, Reich F, Komuniecki E, Chensue SW. Chemokine expression dynamics in mycobacterial (type-1) and schistosomal (type-2) antigen-elicited pulmonary granuloma formation. Am. J. Pathol. 2001;158:1503-1515.
33. Bekker LG, Freeman S, Murray PJ, Ryffel B, Kaplan G. TNF-α controls intracellular mycobacterial growth by both inducible nitric oxide synthase-dependent and inducible nitric oxide synthase-independent pathways. J. Immunol. 2001;166:6728-6734.
34. Balcewicz-Sablinska MK, Keane J, Kornfeld H, Remold HG. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha. J. Immunol. 1998;161:2636-2641.
35. Keane J, Remold HG, Kornfeld H. Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. J. Immunol 2000;164:2016-2020.
36. Spira A, Carroll JD, Liu G, Aziz Z, Shah V, Kornfeld H, Keane J. Apoptosis genes in human alveolar macrophages infected with virulent or attenuated Mycobacterium tuberculosis: a pivotal role for tumor necrosis factor. Am. J. Respir. Cell. Mol. Biol. 2003;29: 545-551.
37. Keane J, Shurtleff B, Kornfeld H. TNF-dependent BALB/c murine macrophage apoptosis following Mycobacterium tuberculosis infection inhibits bacillary growth in an IFN-gamma independent manner. Tuberculosis (Edinb.) 2002;82:55-61.
38. Jung YJ, LaCourse R, Ryan L, North RJ. Virulent but not avirulent Mycobacterium tuberculosis can evade the growth inhibitory action of a T helper 1-dependent, nitric oxide synthase 2-independent defense in mice. J. Exp. Med. 2002;196:991-998.
39. Cooper AM, Adams LB, Dalton DK, Appelberg R, Ehlers S. IFN-γ and NO in mycobacterial disease: new jobs for old hands. Trends Microbiol. 2002;10:221-226.
40. Jung YJ, LaCourse R, Ryan L, North RJ. Evidence inconsistent with a negative influence of T helper 2 cells on protection afforded by a dominant T helper 1 response against Mycobacterium tuberculosis lung infection in mice. Infect. Immun. 2002;70:6436-6443.
41. Hernandez-Pando R, Orozcoe H, Sampieri A, Pavon L, Velasquillo C, Larriva-Sahd J, Alcocer JM, Madrid MV. Correlation between the kinetics of Th1, Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis. Immunology 1996;89:26-33.
42. Orme IM, Roberts AD, Griffin JP, Abrams JS. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J. Immunol. 1993;151:518-525.
43. Hernandez-Pando R, Orozcoe H, Sampieri A, Pavon L, Velasquillo C, Larriva-Sahd J, Alcocer JM, Madrid MV. Correlation between the kinetics of Th1, Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis. Immunology 1996;89:26-33.
44. Rook GA, Seah G, Ustianowski A. M. tuberculosis: immunology and vaccination. Eur. Respir. J. 2001;17:537-557.
45. + cells in vivo during Mycobacterium tuberculosis infection. J. Immunol. 2004;172:6846-6857.
46. Saukkonen JJ, Bazydlo B, Thomas M, Strieter RM, Keane J, Kornfeld H. β-chemokines are induced by Mycobacterium tuberculosis and inhibit its growth. Infect. Immun. 2002;70:1684-1693.
47. Gardam MA, Keystone EC, Menzies R, Manners S, Skamene E, Long R, Vinh DC. Antitumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect. Dis. 2003;3:148-155.